MolNFT v1 · #128001 · protein
NMR structural characterisation of pharmaceutically relevant proteins obtained through a novel recombinant production: the case of the pulmonary surfactant polypeptide C analogue rsp-C33LEU.
5NDA · Rsp-C33LEU -recombinant pulmonary surfactant-associated…: “NMR structural characterisation of pharmaceutically relevant proteins obtained through a novel recombinant…”. Solution nmr. MolNFT v1 #128001 on GenesisL1: 3D structure…
- PDB
- 5NDA
- Type
- protein
- Length
- 33 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Rsp-C33LEU -recombinant pulmonary surfactant-associated polypeptide C analogue-
Structure
solution nmr · 1 distinct chain · 73% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Rsp-C33LEU -recombinant pulmonary surfactant-associated polypeptide C analogue- | protein | 33 | 73% helix, 0% strand | — |
Compared structures
- 5NDA · NMR Structural Characterisation of Pharmaceutically Relevant Proteins Obtained Through a… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 5NDA · PDBe 5NDA
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.